Author response for "A look to the future in non‐alcoholic fatty liver disease: Are GLP ‐1 analogues or SGLT ‐2 inhibitors the answer?"

Author(s):  
Rebecca K Vincent ◽  
David M Williams ◽  
Marc Evans
Sign in / Sign up

Export Citation Format

Share Document